Study start date (mm/dd/yyyy),Study end date (mm/dd/yyyy),Study length (days),Is top-level row?,Subgroup,Positive/negative cases,End-point vs Active,Survivors,Discharged,Contains Any Treatment?,ICU vs. non-ICU,Severity,Ventilation,Median Age,Mean Age
12/29/19,1/31/20,33,Top-level,General,Positive only,End-point only,Both,Both,Yes,Both,All,Both,56,
12/29/19,1/31/20,33,Subgroup,Non-survivors,Positive only,End-point only,Non-Survivors only,Non-discharged only,Yes,Both,Severe/Critical Only,Both,69,
12/29/19,1/31/20,33,Subgroup,Survivors,Positive only,End-point only,Survivors only,Discharged only,Yes,Both,All,Both,52,
1/18/20,2/3/20,16,Top-level,General,Positive only,End-point and active,Both,Both,Yes,Both,All,Both,58,
1/18/20,2/3/20,16,Subgroup,With treatment,Positive only,End-point and active,Both,Both,Yes,Both,All,Both,58,
1/18/20,2/3/20,16,Subgroup,Control,Positive only,End-point and active,Both,Both,Yes,Both,All,Both,58,
12/20/19,2/8/20,50,Top-level,General,Positive only,End-point and active,Both,Both,No,Both,All,Both,50,49.5
12/20/19,2/8/20,50,Subgroup,Subclinical,Positive only,End-point and active,Both,Both,No,Both,All,Both,,44.9
12/20/19,2/8/20,50,Subgroup,Scans done <= 1 week after symptom onset,Positive only,End-point and active,Both,Both,No,Both,All,Both,,48.8
12/20/19,2/8/20,50,Subgroup,Scans done 1-2 weeks after symptom onset,Positive only,End-point and active,Both,Both,No,Both,All,Both,,52.3
12/20/19,2/8/20,50,Subgroup,Scans done >2 weeks after symptom onset,Positive only,End-point and active,Both,Both,No,Both,All,Both,,49.5
1/17/20,2/15/20,29,Top-level,,Positive only,End-point and active,Survivors only,Both,Yes,Non-ICU only,Mild only,Both,,45.11
1/12/20,2/6/20,25,Top-level,Non-severe only,Positive only,End-point only,Both,Discharged only,No,ΝΑ,Mild only,Both,40,40
1/21/20,2/7/20,17,Top-level,General,Positive only,End-point and active,Both,Both,No,ΝΑ,All,,52,52
1/21/20,2/7/20,17,Subgroup,Non-severe only,Positive only,End-point and active,Both,Both,No,ΝΑ,Mild only,,45,45
1/21/20,2/7/20,17,Subgroup,Severe,Positive only,End-point and active,Both,Both,No,ΝΑ,Severe/Critical Only,,69,69
2/12/20,3/2/20,19,Top-level,Severe,Positive only,End-point and active,Both,Both,Yes,ICU only,Severe/Critical Only,Ventilation only,69.4,69.4
3/1/20,3/20/20,19,Subgroup,Severe,Positive only,End-point only,Non-Survivors only,Both,No,ΝΑ,Severe/Critical Only,,78.5,80
1/20/20,2/16/20,27,Top-level,,Positive only,End-point and active,Survivors only,Both,Yes,,All,,50,
1/20/20,2/16/20,27,Subgroup,Severe Cases,Positive only,End-point and active,Survivors only,Both,,,Severe/Critical Only,,66,
1/20/20,2/16/20,27,Subgroup,Mild Cases,Positive only,End-point and active,Survivors only,Both,,,Mild only,,49,
1/10/20,1/26/20,16,Top-level,General,Positive only,End-point and active,Both,Both,Yes,Both,All,Both,41,41
1/10/20,1/26/20,16,Subgroup,> 10 days after onset,Positive only,End-point and active,Both,Both,Yes,Both,All,Both,45,45
1/10/20,1/26/20,16,Subgroup,<=10 days after onset,Positive only,Active only,Both,Non-discharged only,Yes,Both,All,Both,39,39
1/17/20,2/29/20,43,Subgroup,Combination therapy group,Positive only,End-point and active,Both,Both,Yes,ΝΑ,All,,,41.8
1/17/20,2/9/20,23,Subgroup,Monotherapy group,Positive only,End-point and active,Both,Both,Yes,ΝΑ,All,,,47.25
1/10/20,2/18/20,39,Top-level,General,Positive only,End-point and active,Both,Both,Yes,Both,All,,,44.48
1/10/20,2/18/20,39,Subgroup,Asymptomatic/Mild,Positive only,End-point and active,Both,Both,Yes,Non-ICU only,Mild only,Non-ventilation only,,35.96
1/10/20,2/18/20,39,Subgroup,Moderate,Positive only,End-point and active,Both,Both,Yes,Non-ICU only,Mild only,Both,,44.47
1/10/20,2/18/20,39,Subgroup,Severe/Critical,Positive only,End-point and active,Both,Both,Yes,ICU only,Severe/Critical Only,Both,,60.09
12/11/19,1/29/20,49,Top-level,General,Positive only,End-point and active,Both,Both,Yes,Both,All,Both,47,
12/11/19,1/29/20,49,Subgroup,Non-Severe,Positive only,End-point and active,Both,Both,Yes,Both,Mild only,Non-ventilation only,45,
12/11/19,1/29/20,49,Subgroup,Severe,Positive only,End-point and active,Both,Both,Yes,Both,Severe/Critical Only,Both,52,
12/11/19,1/29/20,49,Subgroup,ICU/Venitlation/Death,Positive and Negative/Unconfirmed,End-point and active,Both,Both,Yes,Both,All,Both,63,
12/11/19,1/29/20,49,Subgroup,Not (ICU/Ventilation/Death),Positive and Negative/Unconfirmed,End-point and active,Survivors only,Both,Yes,Non-ICU only,All,Both,46,
12/16/19,1/2/20,17,Top-level,General,Positive only,End-point and active,Both,Both,Yes,Both,All,Both,49,
12/16/19,1/2/20,17,Subgroup,ICU care,Positive only,End-point and active,Both,Both,Yes,ICU only,All,Both,49,
12/16/19,1/2/20,17,Subgroup,No ICU care,Positive only,End-point and active,Both,Both,Yes,Non-ICU only,All,Both,49,
1/1/20,1/20/20,19,Top-level,General,Positive only,End-point and active,Both,Both,Yes,Both,All,Both,,55.5
2/5/20,2/13/20,8,Subgroup,Severe,Positive only,Active only,Both,Non-discharged only,No,ΝΑ,Severe/Critical Only,,63,
2/5/20,2/13/20,8,Subgroup,Critical,Positive only,Active only,Both,Non-discharged only,No,ΝΑ,Severe/Critical Only,,67,
1/1/20,2/3/20,33,Top-level,General,Positive only,End-point and active,Both,Both,Yes,Both,All,Both,56,56
1/1/20,2/3/20,33,Subgroup,Non-ICU,Positive only,End-point and active,Survivors only,Both,Yes,ICU only,All,Both,66,66
1/1/20,2/3/20,33,Subgroup,ICU,Positive only,End-point and active,Both,Both,Yes,Non-ICU only,Severe/Critical Only,Non-ventilation only,51,51
1/16/20,2/4/20,19,Top-level,General,Positive only,Active only,Survivors only,Both,No,ΝΑ,Mild only,,34,
1/20/20,1/27/20,7,Top-level,General,Positive only,Active only,Survivors only,Discharged only,No,ΝΑ,Mild only,,,49
1/23/20,2/8/20,16,Top-level,General,Positive only,End-point and active,Both,Both,Yes,Both,All,Both,47,
1/23/20,2/8/20,16,Subgroup,Mild,Positive only,End-point and active,Survivors only,Both,Yes,Non-ICU only,Mild only,Both,44,
1/23/20,2/8/20,16,Subgroup,Severe,Positive only,End-point and active,Both,Both,Yes,ICU only,Severe/Critical Only,Both,56,
1/22/20,2/10/20,19,Top-level,General,Positive only,End-point and active,Survivors only,Both,No,ΝΑ,All,,,45.1
1/22/20,2/10/20,19,Subgroup,Discharged,Positive only,End-point only,Survivors only,Discharged only,No,ΝΑ,All,,,34.8
1/22/20,2/10/20,19,Subgroup,Non-Discharged,Positive only,Active only,Survivors only,Non-discharged only,No,ΝΑ,All,,,49.4
12/25/19,2/15/20,52,Top-level,General,Positive and Negative/Unconfirmed,End-point and active,Both,Both,Yes,Both,All,,,70.58
12/25/19,2/15/20,52,Subgroup,Non-survivor,Positive and Negative/Unconfirmed,End-point only,Non-Survivors only,Both,Yes,Both,All,,,78.61
12/25/19,2/15/20,52,Subgroup,Survivor,Positive and Negative/Unconfirmed,End-point and active,Survivors only,Both,Yes,Both,All,,,66.16
2/20/20,3/5/20,14,Top-level,,Positive only,End-point and active,Both,Both,Yes,ICU only,All,,,70
1/23/20,2/25/20,33,Top-level,,Positive only,End-point and active,Survivors only,Both,Yes,Both,All,Both,47,
1/23/20,2/25/20,33,Subgroup,Did not require supplemental oxygen,Positive only,End-point and active,Survivors only,Both,Yes,Both,All,Both,37,
1/23/20,2/25/20,33,Subgroup,Required supplemental oxygen,Positive only,End-point and active,Survivors only,Both,Yes,Both,All,Both,56,
2/15/20,3/17/20,31,Top-level,Non-survivor,Positive only,End-point only,Non-Survivors only,Discharged only,No,ΝΑ,All,Both,80,79.5
12/25/19,1/26/20,32,Top-level,aggregate,Positive only,End-point and active,Both,Both,Yes,Both,All,Both,51,
12/25/19,1/26/20,32,Subgroup,with ARDS,Positive only,End-point and active,Both,Both,Yes,Both,Severe/Critical Only,Ventilation only,58.5,
12/25/19,1/26/20,32,Subgroup,without ARDS,Positive only,End-point and active,Survivors only,Both,Yes,Both,All,Non-ventilation only,48,
2/3/20,2/10/20,7,Subgroup,meplazumab,Positive only,End-point and active,Both,Both,Yes,ΝΑ,All,,51,
2/3/20,2/10/20,7,Subgroup,no meplazumab,Positive only,End-point and active,Both,Both,Yes,ΝΑ,All,,64,
1/20/20,1/31/20,11,Top-level,,Positive only,End-point and active,Both,Both,No,ΝΑ,All,,,46
1/20/20,2/10/20,21,Top-level,All cases,Positive only,End-point and active,Both,Both,No,ΝΑ,All,,47.5,
1/20/20,2/10/20,21,Subgroup,severe,Positive only,End-point and active,Both,Both,No,ΝΑ,Severe/Critical Only,,61.4,
,,0,,,,,,,,,,,,
1/20/20,2/10/20,21,Subgroup,common,Positive only,End-point and active,Survivors only,Both,No,ΝΑ,Mild only,,44.5,
,,0,,,,,,,,,,,,
1/21/20,2/3/20,13,Subgroup,Mild,Positive only,End-point and active,,Both,Yes,,Mild only,,,29.2
1/21/20,2/3/20,13,Subgroup,Common,Positive only,End-point and active,,Both,Yes,,Mild only,,,33.4
1/21/20,2/3/20,13,Subgroup,Severe,Positive only,End-point and active,,Both,Yes,,Severe/Critical Only,,,44.2
1/21/20,2/3/20,13,Subgroup,Critical,Positive only,End-point and active,,Both,Yes,,Severe/Critical Only,,,63
1/24/20,2/14/20,21,Subgroup,FPV,Positive only,End-point and active,Survivors only,Both,Yes,Non-ICU only,All,Non-ventilation only,43,
1/24/20,2/14/20,21,Subgroup,LPV/RTV,Positive only,End-point and active,Survivors only,Both,Yes,Non-ICU only,All,Non-ventilation only,49,
1/1/20,2/21/20,51,Subgroup,Mild,Positive only,Active only,Both,Both,No,Non-ICU only,Mild only,Non-ventilation only,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,
,,,,,,,,,,,,,,